Literature DB >> 28248312

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria.

H Gisslinger, G Jeryczynski, B Gisslinger, A Wölfler, S Burgstaller, V Buxhofer-Ausch, M Schalling, M-T Krauth, A-I Schiefer, C Kornauth, I Simonitsch-Klupp, C Beham-Schmid, L Müllauer, J Thiele.   

Abstract

Entities:  

Year:  2017        PMID： 28248312     DOI： 10.1038/leu.2016.291

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

Review 1.  [WHO classification of myeloid neoplasms].

Authors:  C Wickenhauser
Journal:  Pathologe       Date:  2018-12       Impact factor: 1.011

2.  Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.

Authors:  Claire N Harrison; Adam J Mead; Anesh Panchal; Sonia Fox; Christina Yap; Emmanouela Gbandi; Aimee Houlton; Samah Alimam; Joanne Ewing; Marion Wood; Frederick Chen; Jason Coppell; Nicki Panoskaltsis; Steven Knapper; Sahra Ali; Angela Hamblin; Robyn Scherber; Amylou C Dueck; Nicholas C P Cross; Ruben Mesa; Mary Frances McMullin
Journal:  Blood       Date:  2017-08-09       Impact factor: 22.113

3.  Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency.

Authors:  Hongqiang Jiang; Yanxia Jin; Yufeng Shang; Guolin Yuan; Dandan Liu; Jianfang Li; Cong Wang; Lu Ding; Xiqin Tong; Shishang Guo; Fayun Gong; Fuling Zhou
Journal:  Front Med (Lausanne)       Date:  2021-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.